Organovo Holdings, Inc. announced an exclusive distributor agreement with Cosmo Bio Co. Ltd. for its NovoView Preclinical Services in Japan. Organovo will work with CosmoBio's Drug Discovery Services (DDS) team to gain direct access to customers and support projects throughout the Japanese biopharmaceutical industry.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -0.96% | +11.47% | -7.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.21% | 11.85M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Organovo Holdings Signs Exclusive Distributor Agreement with Cosmo Bio Co., Ltd